A Preview Of TRACON Pharma's Earnings
Portfolio Pulse from Benzinga Insights
TRACON Pharma (NASDAQ:TCON) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.36. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. Shares are currently trading at $0.3354 and have fallen 84.79% over the last 52-week period.
August 11, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TRACON Pharma's upcoming earnings report is expected to show an EPS of $-0.36. The company's past performance shows a trend of missing EPS estimates, which has led to drops in share price. The stock is currently trading at $0.3354 and has fallen 84.79% over the last 52-week period.
TRACON Pharma has a history of missing EPS estimates, which has led to drops in its share price. Given this trend and the current trading price, it's likely that the upcoming earnings report could negatively impact the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100